Supreme Court to review challenge concerning abortion pill distribution

The Supreme Court has announced that it will review the Biden administration's efforts to uphold access to a commonly used abortion pill. This marks the first abortion-related case taken up by the high court since the conservative majority overturned Roe v. Wade last year. The case, brought by a coalition of doctors and medical associations who oppose abortion rights, could have significant implications for the distribution and prescription of the drug mifepristone. The Court's decision, expected by the end of June, will have nationwide effects, even in states where abortion is permitted, as it may impact how the medication is obtained and by whom. The availability of mifepristone will remain unchanged until the final decision is rendered. Stay tuned for updates on this developing news story.